Xpect Stopain Clinical Gel
Product Images NDC 42961-256

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Xpect Stopain Clinical (NDC 42961-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cintas Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Packet1 (Packet1)

Packet1 (Packet1)
This text describes a clinical maximum performance pain relief gel designed to provide immediate and penetrating relief from arthritis, muscle aches, joint pain, and back pain. The gel contains 10% menthol, along with MSM and Glucosamine. The product appears to come in a 3g package.*
FDA Label Image

Packet2 (Packet2)

Packet2 (Packet2)
This text provides detailed information about a Menthol-based topical pain relief product, including its active ingredient, uses, warnings, directions for use for adults and children over 2 years old, and information on inactive ingredients. It mentions restrictions like not using the product on children under 2 years old without consulting a doctor, avoiding contact with eyes, not bandaging tightly, and not using more than 30 times a day. It also includes manufacturer details and contact information in case of emergency.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.